- Home
- Clinical Trials
Weight Loss with Diabetes Study Sydney SL NN
Weight loss with Diabetes (Reimagine) Study
St Leonards Sydney
Are you living with overweight/obesity and suffer from Type 2 diabetes? Join our weight loss research study exploring a new investigational treatment to see how effectively it can improve blood sugar levels and help you lose weight.
Eligible participants will be provided with the corresponding treatment free of charge and will be closely monitored by our medical team throughout the research project.
Description
What to expect
Study details
Ages
18+ years
Duration
Up to 69 weeks
Compensation
Eligible participants will be provided with the corresponding treatment free of charge and will be compensated for travel related expenses upon completion of each scheduled clinic visit.
Eligibility Criteria
You may be eligible to take part if you:
- Are 18 years of age or older
- Have a BMI ≥ 30 kg/m2
- Have been formally diagnosed with Type 2 Diabetes AND
- Take metformin or an SGLT2 inhibitor (e.g., Jardiance, Forxiga) as part of your regular treatment.
Locations
Description
Type 2 diabetes is a condition where the body can't properly control blood sugar levels due to inadequate insulin production or effectiveness. High blood sugar can eventually harm both small and large blood vessels, leading to cardiovascular issues. As of 2021, about 537 million people worldwide were living with diabetes, and projections suggest this number could increase to 783 million by 2045. Type 2 diabetes constitutes over 90% of these cases, with 80-90% of sufferers being overweight or obese.
Weight loss can significantly improve how the body uses insulin and controls blood sugar by reducing fat in the liver and pancreas. Current health guidelines stress that managing weight is vital in treating Type 2 diabetes.
What to expect
We are conducting a new weight management study for adults suffering from Type 2 diabetes – The REIMAGINE-5 Research Project.
The purpose of the research project is to compare a potential new weight loss treatment called CagriSema** when compared with Tirzepatide (also known by its commercial name Mounjaro®) in people with Type 2 Diabetes.
**CagriSema is NOT available for purchase by the general public.
The research project consists of three periods:
• Screening Period: 3 weeks (approx.)
• Treatment Period: 60 weeks.
• Follow-up Period: 6 weeks.
The maximum duration of the study for each participant is 69 weeks.
Eligible participants will be provided with the corresponding treatment free of charge and will be closely monitored by our medical team throughout the research project. Additionally, they will be compensated for travel related expenses upon completion of each scheduled clinic visit.
Apply now
Fill out your details, and our team will be in touch to discuss your potential involvement in this study and answer any questions you may have.
*You can unsubscribe or opt out at any time.
- We collect personal information, such as your name, address and contact details, and details of your medical conditions, that enables us to identify if you may be eligible to participate in a current or future study. On occasion we may also contact people on our database by email, with general news and information relevant to our studies and volunteers. By submitting this form you agree to receive email and text notifications about this and other enrolling studies. You can unsubscribe or opt out at any time. We do not sell, share or distribute our database under any circumstances.
- We will collect this information directly from you. If you consent to release of medical records, we will obtain medical information from other agencies on your behalf if these are required for your participation in any clinical study at Momentum Clinical Research.
- Security of your information is important. Personal information collected is stored by third party data storage providers. We believe these providers offer safe and secure systems.
- All information we collect about you will be treated with confidentiality and can be accessed only by Momentum Clinical Research employees.
- By completing our online enrolment form, or any other forms we send you, you agree to us holding your personal details within our databases.
- There is no obligation for you to participate in a study that we contact you about. If you decline to participate in a study, that will not affect your eligibility for participation in another study.